Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F P Tally

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Expert Opinion on Investigational Drugs|July 5, 2005
Daptomycin: a novel agent for Gram-positive infectionsF P Tally, M Zeckel, M M Wasilewski, et al.
Annals of Internal Medicine|September 1, 1975
Management of anaerobic infectionsS M Finegold, J G Bartlett, A W Chow, et al.
American Journal of Surgery|January 1, 1983
Improved localization and survival in patients with intraabdominal abscessesS Saini, J M Kellum, M P O'Leary, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1990
Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis groupG J Cuchural, F P Tally, N V Jacobus, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2000
Drug target validation: lethal infection blocked by inducible peptideJ Tao, P Wendler, G Connelly, et al.
Journal of Medicinal Chemistry|January 7, 1994
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclinesP E Sum, V J Lee, R T Testa, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1991
Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosomeB Rasmussen, H F Noller, G Daubresse, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolationG J Cuchural, F P Tally, N V Jacobus, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1985
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United StatesF P Tally, G J Cuchural, N V Jacobus, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1984
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982G J Cuchural, F P Tally, N V Jacobus, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Expert Opinion on Investigational Drugs|July 5, 2005
Daptomycin: a novel agent for Gram-positive infectionsF P Tally, M Zeckel, M M Wasilewski, et al.
Annals of Internal Medicine|September 1, 1975
Management of anaerobic infectionsS M Finegold, J G Bartlett, A W Chow, et al.
American Journal of Surgery|January 1, 1983
Improved localization and survival in patients with intraabdominal abscessesS Saini, J M Kellum, M P O'Leary, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1990
Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis groupG J Cuchural, F P Tally, N V Jacobus, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2000
Drug target validation: lethal infection blocked by inducible peptideJ Tao, P Wendler, G Connelly, et al.
Journal of Medicinal Chemistry|January 7, 1994
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclinesP E Sum, V J Lee, R T Testa, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1991
Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosomeB Rasmussen, H F Noller, G Daubresse, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolationG J Cuchural, F P Tally, N V Jacobus, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1985
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United StatesF P Tally, G J Cuchural, N V Jacobus, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1984
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982G J Cuchural, F P Tally, N V Jacobus, et al.
Pageof 13